Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
$73.91
-0.66%
(-0.49) 1D
$73.91
0.00% (0.00)
After hours
Closed: Apr 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARWR...
Open
$74.29
High
$75.32
Low
$73.26
Mkt. cap
10.35B
Avg. vol.
2.28M
Volume
1.64M
P/E ratio
47.96
52-wk high
$76.76
52-wk low
$12.44
EPS
$1.54
Beta
1.26
Shares outstanding
140.03M
No. of employees
711
News stories
From sources across the web
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitearrowheadpharma.com
Last report
Feb 5, 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
0.22/ (-0.37 est.)USD
+159.86%beat
Revenue / Estimate
264.03M/ (230.85M est.)USD
+14.38%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
542.71M
27.77M
256.47M
264.03M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
125.41M
155.91M
181.07M
173.52M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36.09M
37.41M
31.29M
49.70M
Operating expense
161.51M
193.32M
212.37M
223.22M
Total operating expenses
161.51M
193.32M
212.37M
223.22M
Operating income
381.20M
-165.55M
44.11M
40.81M
Other non operating income
438.00K
-176.00K
4.66M
277.00K
EBT including unusual items
369.62M
-179.09M
36.12M
28.27M
EBT excluding unusual items
369.62M
-179.09M
36.12M
28.27M
Income tax expense
1.75M
-437.00K
20.00M
29.00K
Effective tax rate
0.47%
0.24%
55.37%
0.10%
Other operating expenses
-
-
-
-
Net income
370.44M
-175.24M
-23.75M
30.81M
Net profit margin
68.26%
-631.11%
-9.26%
11.67%
Earnings per share
2.75
-1.26
-0.18
0.22
Interest and investment income
9.62M
11.02M
9.05M
9.69M
Interest expense
-21.64M
-24.38M
-21.69M
-22.50M
Net interest expenses
-12.02M
-13.36M
-12.64M
-12.82M
Depreciation and amortization charges
-
-
-
-
EBITDA
387.29M
-159.33M
50.49M
47.20M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer